Webinars

​Agilex Biolabs   →  Webinars

Webinars

  • All
  • Australian Advantage
  • Bio-Blog
  • 사례 연구
  • Central Lab Services
  • Pharmacodynamics
Want to reduce time and cost of clinical development? A webinar revealing why sponsors are increasingly outsourcing clinical trials to Australia
Want to reduce time and cost of clinical development? A webinar revealing why sponsors are increasingly outsourcing clinical trials to Australia
이상하고 놀라운 사례 연구: 예상치 못한 바이오 분석 과제에 대한 실제 솔루션
애질렉스 바이오랩의 강점인 구조 연구는 바이오 분석 전문가들이 "이상하고 경이로운" 문제를 해결하기 위해 노력하는 곳입니다.
순환하는 종양 DNA의 점 돌연변이를 식별하고 정량화합니다: ddPCR 접근법™
순환 종양 DNA(ctDNA)는 종양에서 직접 유래하거나 순환하는 종양 세포에서 유래하는 종양 유래 단편화된 DNA입니다.
복잡한 면역원성 문제 해결
복잡한 생물학적 분석 면역원성 문제 해결
MetID로 체외 데이터와 임상 결과를 연결하기
MetID로 체외 데이터와 임상 결과를 연결하기
호주에서 독성학을 한다는 사실을 알고 계셨습니까?
호주에서 독성학을 한다는 사실을 알고 계셨습니까?
Ensuring sample integrity from collection to analysis
With increasingly novel drug development programs, meaningful collection of subject samples has never been more relevant. Don’t let potential analyte instability mislead your program as it gets underway, causing costly time delays
Watch Endpoints Webinar: Non-clinical and clinical pathways for rapid vaccine development in Australia
Watch Endpoints Webinar: Non-clinical and clinical pathways for rapid vaccine development in Australia
Agilex Biolabs Partners with Endpoints News for the First Webinar on Rapid Vaccine Development in Australia
Agilex Biolabs, the Australian specialist bioanalytical and toxicology laboratory facilities for clinical trials is partnering with Endpoints News to share the latest on “Non-clinical and clinical pathways for rapid vaccine development in Australia”, in a webinar hosted by Endpoints News Editor Arsalan Arif.
Endpoints Webinar: Deconvoluting inflammation and immunology for clinical trials
Inflammation is a complex biological process involving a host of resident and recruited immune cells which are mobilized to infiltrate tissues in response to invading pathogens. These immune cells boast elevated numbers and heightened activation as they churn out inflammatory mediators, which act in unison to coordinate and modulate the immune response.Choosing the right bioanalytical platform for your immunology clinical trial is critical to data collection. But navigating the intricate inflammation process can be difficult. What do these platforms look like in use, and how should you go about selecting the right one?
Agilex Biolabs Partners with Endpoints News on Deconvoluting Inflammation and Immunology for Clinical Trials
Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials is partnering with Endpoints News to share the latest on deconvoluting inflammation and immunology for clinical trials, in a webinar hosted by Endpoints News Editor Arsalan Arif.
Hot topics in Immunoassay Bioanalysis
This webinar examines the hot topics in immunoassay bioanalysis for biotechs navigating the immunogenicity and biomarker requirements for clinical trials. Join the discussion with panelists from Agliex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, and B2S Life Sciences, a biotherapeutic enablement company advancing improved analytical methods and outcomes for developers of biotherapeutic drugs and diagnostics
Endpoints Webinar: Leveraging APAC partnerships to de-risk clinical trials
Demand for APAC clinical trials is still on the rise as COVID numbers continue to fall across the region attracting biotechs wanting to restart stalled or paused clinical trials from around the globe. Indeed Australia recorded zero new cases in the past 25 days.
Endpoints News webinar – new client portal GALEXI™
Endpoints News webinar - new client portal GALEXI™
Endpoints News Webinar: Why Australia is the World’s Leading Early Phase Destination – plus up to 50% cost savings
Why Australia is the World’s Leading Early Phase Destination – Rapid Start-up, No IND Required, and a Government-Backed Refund on Almost Half of all Trial Costs Increasingly Sponsors are wanting to be actively involved in the core clinical partner selection because they matter to the success of their clinical research.
Endpoints Webinar (transcript): Why Australia is the World Leader for Phase 1 Trials
애자일렉스 바이오랩스
Agilex Biolabs Develops World’s Most Accurate Cannabinoid Assay
Award-winning Agilex Biolabs, the Asia-Pacific region’s leading bioanalytical laboratory for clinical trials, based in Australia, has developed the world’s most accurate cannabinoid assay.
Endpoints Webinar: How Easy is it to Move Your Trial to Australia?
Gathering together the key clinical service providers for a trial can be a daunting process – especially if you are going off-shore to reactivate trials or start new trials to make up for COVID delays.However, Australia offers a refreshingly streamlined process because of its group of proven top-tier providers that regularly work together so are fully engaged and in sync with processes and each other’s requirements and capabilities. This makes setting up trials in Australia a smooth, professional, and rapid process for biotechs. This webinar looks at how moving trials to Australia could be much easier than you think.
Endpoints Webinar: (Transcript) The Australian Advantage, de-risk your early phase trials
애자일렉스 바이오랩스
Agilex Biolabs and Endpoints News Present ‘How to Move Trials to Australia’ Webinar
Agilex Biolabs, Australia’s largest specialist bioanalytical laboratory for clinical trials, and Endpoints News launched a new webinar “How Easy is it to Move Your Trials to Australia” at BIO Asia-Taiwan 2020.
Bio Korea 2020: Agilex Biolabs Presents the Australian Clinical Trials Advantage
Agilex Biolabs, Australia’s largest specialist bioanalytical laboratory for biotech clinical trials, is presenting the Australian Advantage including the world’s most attractive rebate on clinical trials costs, at BIO Korea 2020.
Agilex Biolabs Presents at OCT (transcript)
애자일렉스 바이오랩스
Lab Tour Video
Lab Tour Video
Agilex Biolabs at BIO Korea 2020– Dr Kurt Sales presents the Australian Advantage
Agilex Biolabs at BIO Korea 2020– Dr Kurt Sales presents the Australian Advantage
Agilex Biolabs featured in Endpoints News
One of the most important drug development start-up decisions is finding a centrally located bioanalytical laboratory that can support clinical research across all the study locations, and through pre-clinical then potentially for all Phases.Quality control and consistency of sample management and analysis from early Phase onwards can make a real difference to quality of data and final outcomes.
Endpoints News webinar: featuring Agilex Biolabs Dr Kurt Sales.
Endpoints News webinar: featuring Agilex Biolabs Dr Kurt Sales.